The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S1
Journal	European journal of endocrinology / European Federation of Endocrine Societies
Volume	156 Suppl 1
Publication status	Published - Apr 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{92ae7aa4739c487fba6a974d6c133fb9,

title = "The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.",

author = "A. Colao and Hofland, {L. J.}",

year = "2007",

month = apr,

language = "English",

volume = "156 Suppl 1",

pages = "S1",

journal = "European journal of endocrinology / European Federation of Endocrine Societies",

issn = "0804-4643",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.

AU - Colao, A.

AU - Hofland, L. J.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=79959337536&partnerID=8YFLogxK

UR - https://academic.oup.com/ejendo/article-abstract/156/Supplement_1/S1/6695805?redirectedFrom=fulltext&login=false#no-access-message

M3 - Article

C2 - 17413182

AN - SCOPUS:79959337536

SN - 0804-4643

VL - 156 Suppl 1

SP - S1

JO - European journal of endocrinology / European Federation of Endocrine Societies

JF - European journal of endocrinology / European Federation of Endocrine Societies

ER -